Aortic Stenosis with High Gradients and Area >1: Just Follow Up?

Definig severe aortic stenosis (AS) rests upon Doppler parameters, and uses log-established cutoff values, which include peak velocity (PV) ≥ 4 m/s, mean gradient (MG) ≥ 40 mmHg and aortic valve area (AVA) ≤ 1 cm². However, there are value discrepancies in up to 30-40% of cases, which has given way to different clinical profiles. 

angulación aórtica post TAVR

One of the discrepant phenotypes corresponds to patients with high gradients (HG) and AVA > 1 cm². Their management and prognosis has hardly been approached by clinical guidelines. The aim of this study was to look into the clinical and hemodynamic characteristics of this group and compare their mortality against other AS subtypes. 

This was a retrospective study on echocardiographic data from the Mayo Clinic (Minnesota, EE. UU.). It included patients with AS diagnosis classified according to AVA, PV and MG into four groups. Patients with prior valve surgery, left ventricular outflow tract obstruction, mitral or aortic insufficiency or mitral stenosis were excluded. Primary outcome was all cause mortality. 

Data from 3,209 were collected, distributed by hemodynamic characteristics as follows: 7.2% phenotype AG-AVA > 1, 45.9% phenotype HG-AVA ≤ 1, 14.3% low gradient phenotype with AVA ≤ 1 (LG-AVA ≤ 1), and 32.6% moderate AS.

HG-AVA > 1 patient mean age was 70.2 ± 12 years, making this the youngest of subtypes (P < 0.01), also presenting higher prevalence of male sex (85.7%), larger body surface and body mass index (BMI), and higher incidence of bicuspid aortic valve (39.6%). They had fewer comorbidities and lower levels of natriuretic peptide type B (BNP). PV and MG values were lower vs. phenotype AVA ≤ 1 (P < 0.01), while 115.0 ± 19 mL systolic volume (SV) and 54.8 ± 10.5 mL/m² indexed value (SV index) were higher.

Read also: SCAAR Registry: Coronary Angioplasty in Venous Grafts.

During a 944-day followup, there were 1,523 deaths (47.5%). Phenotype HG-AVA > 1 presented 38.9% mortality rate at 5 years, and 59.6% at 8 years. After adjusting for age, mortality in this group resulted similar to that of moderate AS patients, but lower vs. phenotype LG-AVA ≤ 1 (HR: 1.9 [CI 95%: 1.4-2.4]; P < 0.01).

As regards aortic valve replacement (AVR), mainly surgical (12.9% were TAVR), 67.4% of patients with HG-AVA > 1 were treated, vs. 69% of HG-AVA ≤ 1, 32.8% of LG-AVA ≤ 1 and 34.7% of moderate AS patients. Mortality in AVR patients, resulted higher in patients with AVA ≤ 1, both for HG (HR: 1.5 [CI 95%: 1.1-2.0]; P = 0.03) and LG patients (HR: 2.4 [CI 95%: 1.6-3.5]; P < 0.001).

Mortality rate for patients with HG-AVA > 1 undergoing AVR was superior to that of one controlled matched population, but significantly lower to that of HG-AVA > 1 patients not operated on (mortality rate 8.2 [CI 95%: 5.9-11.2]).

Conclusions

In this cohort of patients with AS, individuals with high gradients and > 1 cm² valve area were characterized for being younger, and have lower comorbidities vs. other phenotypes. Presented higher survival, expect for a matched population. Aortic valve replacement showed an 8-year survival benefit vs. the non-treated, which suggests a positive impact of surgery for this specific group. 

Original Title: High-Gradient Aortic Stenosis With Valve Area >1.0 cm2 The “Forgotten” Discordant Hemodynamic Phenotype.

Reference: Ito S, Oh JK, Michelena HI, Egbe AC, Connolly HM, Pellikka PA, Nkomo VT, Lewis BR, Miranda WR. High-Gradient Aortic Stenosis With Valve Area >1.0 cm2: The “Forgotten” Discordant Hemodynamic Phenotype. JACC Cardiovasc Imaging. 2024 Sep 5:S1936-878X(24)00315-2. doi: 10.1016/j.jcmg.2024.07.025. Epub ahead of print. PMID: 39297851.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...